Fiocruz registers new drug for hepatitis C – Revista News
The Institute of Pharmaceutical Technology (Farmanguinhos) of the Oswaldo Cruz Foundation (Fiocruz) signed a partnership agreement to register ravidasvir, a ...
The Institute of Pharmaceutical Technology (Farmanguinhos) of the Oswaldo Cruz Foundation (Fiocruz) signed a partnership agreement to register ravidasvir, a ...
Hepatitis is a silent disease that can have fatal consequences. Approximately 80% of people infected with the Hepatitis C virus ...
Join over 12.000+ subscribers & be the first to get new freebies.
[mc4wp_form]
This demo site is only for demonstration purposes to JNews WordPress theme. All images are copyright to their respective owners. All content cited is derived from their respective sources.